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IMPROVING HEALTH IN DEVELOPING 
COUNTRIES1
 
 - REDUCING COMPLEXITY OF DRUG 
SUPPLY CHAINS 
 
 
 
 
ABSTRACT 
Purpose of this paper  
Uganda is one of many African countries struggling to develop adequate healthcare, 
particularly in regard to local treatment and access to drugs. The purpose of this paper is to 
contribute to the understanding of how reducing supply-chain complexity can improve 
health in developing countries. 
 
Design/methodology/approach 
This study and evaluation included 50 interviews and 27 site visits of the public healthcare 
system in Karamoja, northeast Uganda. A mapping of drug-supply chains was undertaken 
to identify causes of stock shortages and possible solutions. A model for logistics process 
redesign was used for the analysis. Results were quantified with use of a simple tool 
developed for this specific purpose.  
 
Findings 
The main conclusion is that less supply-chain complexity can produce higher customer 
service in terms of less stock shortages, while keeping costs down. By reducing lead times 
and uncertainty, increasing order frequencies, and moving order points and safety stocks, 
there may be better integration between information and goods flows and bottlenecks in 
the supply chain may be reduced.  
 
Research limitations/implications 
While the empirical study is extensive, there are uncertainties in the data that must be taken 
into account. The effects of the suggested solutions remain to be analyzed and documented 
upon implementation. 
 
                                                 
1The definition of developing countries and use of the concept is up for discussion (Rosling, 2011). Countries 
traditionally classified as developing, such as China (see, for example, UNICEF, 2011), are increasingly referred 
to as emerging economies. What is common for most of these countries is poverty and lack of, or weak, 
infrastructures compared to others. 
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Practical implications 
The study was rooted in a practical problem and provides practical solutions for 
developing countries and agencies providing aid. 
 
Social implications 
Stock shortages of life-saving drugs are a general problem in countries with lack of 
financial and technical infrastructure. Improvements will impact the lives of many people. 
 
Value of the paper 
The paper provides an understanding of the applicability of traditional logistics principles 
in a new context. It provides the academic community with a much-needed in-depth 
understanding of humanitarian logistics. The approach can be used in other studies 
 
Keywords: drug, supply chain, health, Africa, development, stock shortages. 
 
Type of paper: Research paper 
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1. INTRODUCTION AND PURPOSE 
During the past four years, humanitarian logistics has attracted a lot of attention in academia, 
with an immense growth in published articles. However, the research suffers from a lack of 
facts and knowledge about humanitarian logistics practice (Kovács and Spens, 2009; 2011a; 
b; Jahre et al. 2009; Pedraza Martinez et. al. 2011). Little has been published on logistics in 
long-term development and distribution of goods in developing countries (Kovács and Spens, 
2011a). While often seen as limited to disaster relief logistics (see e.g., Tatham and Pettit, 
2010; McLachlin and Larson, 2011), recent statements now include ‘development’ as part of 
humanitarian logistics (e.g., Kovács and Spens, 2011b, p.8). Furthermore, practitioners and 
researchers increasingly note the importance of linking disaster relief with recovery and 
development (e.g. IFRC-Strategy 2020, 2011; Kovács and Spens, 2011a; Besiou et al., 2011). 
Humanitarian logistics research should thus take this into account. 
 
The purpose of this paper is to contribute to understanding of traditional logistical tools and 
principles to improve development aid. The paper reports a study of drug-supply chains in 
Uganda, focusing on causes of, and solutions to, frequent stock shortages. As with many 
African countries, Uganda is struggling to develop adequate healthcare systems (Kumar et 
al., 2009). A survey reveals that 32–50 percent of medicines essential for treating common 
diseases, such as malaria, pneumonia, diarrhoea, HIV/AIDS, tuberculosis, diabetes, and 
hypertension, are not available (Okiror, 2009). Sixty-five percent of facilities across Uganda 
experienced medical stock shortages in 2008 (MoH, 2009). One critical problem is 
establishing supply chains for drugs and medical equipment to ensure availability at local 
treatment facilities (that is, health centers). Stock shortages are a general problem for many 
drug-supply chains in countries with a lack of financial resources, health system 
infrastructures, capacities, and competencies (see e.g., GAVI, 2009; Lalvani et. al. 2010; 
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Kaufmann et. al. 2011). Hence, knowledge of the causes and possible solutions for drug 
shortages is of interest outside the specific region where this study was undertaken. 
 
This study used a basic model for logistics process redesign (Persson, 1995), supplemented 
by additional literature, as the conceptual framework to describe and analyze the public drug-
supply chain in the Karamoja region of Uganda. This paper provides knowledge on the link 
between logistics processes, such as ordering and inventory management, and performance 
(Lodree, 2011, p.52). The research helps fill a gap in humanitarian literature on logistics 
process redesign while expanding this literature to a new area (see Pedraza Martinez et al. 
2011 for similar research in fleet management). 
 
The study took place in 2009–2010 with more than 50 interviews and 27 site visits at health 
facilities undertaken during a period of four months. Logistics processes and performance 
such as ordering, warehousing, stock shortages, lead times and management techniques were 
assessed. Findings suggest that reducing supply-chain complexity and bureaucratic processes 
resulting in long lead times and instability, can improve integration between information and 
goods flows to increase customer service, i.e. reduce stock shortages. A simple Excel 
worksheet model demonstrates how suggested solutions can reduce lead times and costs, 
making the right drugs available where and when they are needed. The following presents the 
design of the study, followed by a description of the context. The conceptual framework is 
presented, whereupon findings from the study are reported and discussed. Finally, 
conclusions and implications for further research are presented. 
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2. RESEARCH STRATEGY AND DESIGN 
The study was undertaken as a project for UNICEF Uganda and can be characterized as 
action research. Researchers and clients collaborate in diagnosing the problem and 
developing solutions, typically focused on real-world, organizational and managerial 
problems (Bryman and Bell, 2011, p.412; Näslund, 2002; Näslund, 2008).  
 
This study used a mixed-methods approach, combining quantitative and qualitative research 
strategies (Bryman and Bell, 2011, p.628). It used different sources and types of data for 
complementarity and to cross-reference information (Ellram, 1996; Yin, 2003). First, an 
explorative study corroborated secondary and primary data to give an overall description of 
the health provision in Uganda and specific characteristics of Karamoja. This is the context 
for the supply chain in question. Second, conclusions from this initial phase were used to 
choose a suitable conceptual framework from which interview guides and field-study stock-
assessment tools were developed. Third, results from this cross-sectional study were used to 
get an overview of lead times, costs and stock shortages. From this analysis, solutions were 
suggested, whereupon an Excel worksheet model was developed to demonstrate 
consequences of the solutions.  
 
2.1 The case and context 
The case and unit of analysis is the supply chain for drugs from the national distribution point 
in Kampala, Uganda, called National Medical Stores (NMS), to health centers (HCs) in five 
districts in the Karamoja region of northeastern Uganda. Primary data were gathered through 
interviews with stakeholders in Kampala and Karamoja, and combined with secondary data 
from the literature review. Approximately 1,500 pages of articles and reports were identified 
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in the interviews and through web searches. These data were reviewed to understand the 
health system, pinpointing constraints, opportunities, and best practices.1
 
 The interviewees 
were identified through snowball sampling (Bryman and Bell, 2011, p.192), starting with a 
small group of people suggested by UNICEF. This was done to get as many perspectives on 
the health supply chain and its challenges as possible, covering all main stakeholders. 
From a total of 94 HCs in Karamoja, 27 were chosen for site visits, interviews and stock 
assessments. This provided 28.7 percent coverage, relatively equally distributed across each 
of the five Karamoja districts. The HCs within each district were selected through 
convenience sampling to cover both remote and urban areas, and well- and poor-functioning 
centers. The five district medical stores (DMS) maintaining medical supply stocks were also 
visited (Appendix 1). Six types of drugs, pre-selected by UNICEF, were used as tracer drugs 
for this part of the study: artimisinin-based combination therapy (ACTs such as Coartem; 
malaria pills in four sizes), sulfadoxine pyrimethamine (malaria treatment), co-trimoxazole 
(antibiotic for bacterial infections, particularly for HIV/AIDS patients, in four sizes), oral 
rehydration salt (diarrhea treatment), medroxyprogesterone injection (birth control), and 
measles vaccine.  
 
The interviews were structured using a guide which was tested and revised (Bryman and Bell, 
2011, p. 273). Each interview lasted two to four hours, including stock assessment and site 
visit. Interviews were conducted individually with key informants or in groups, depending on 
the contact person’s preference and the number of people working in a facility (Appendix 2). 
Starting with general questions, the interviews covered eight themes, including human 
resources and staff capacity, forecasting requirements, ordering, receiving and sending 
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routines, inventory management and the physical condition of facilities. Almost all interviews 
were done by two researchers, one asking and one taking notes. The field context was 
challenging, with 5,000 km at a speed of 30 km per hour on dirt roads, wearing bulletproof 
vests and helmets (Jahre, 2010).  
 
The interview guide2
 
 as well as the study protocol was refined during the process. Data were 
written up in individual Word documents and Excel worksheets, forming a database. 
Everything was then compiled in one common worksheet and cross-analyzed for each theme 
to identify patterns. More detailed analysis of particular issues was undertaken. The results 
were discussed with stakeholders. Based on the field assessment in Karamoja, together with 
the explorative study, the supply chain was mapped in accordance with the conceptual 
framework, and possible solutions were identified. Consequences of the solutions for costs 
and customer service were then quantified to compare before and after implementation of 
solutions. 
2.2 Evaluation of research design 
In spite of the special challenges posed in doing research in this particular context, major 
efforts were made to ascertain rigor and secure validity and reliability.  
 
Table 1: Securing validity and reliability (adapted from Bryman and Bell, 2011) 
Quality measure Mitigation strategy 
Limitations with 
secondary data 
Lack of familiarity with 
data 
Use of experts and establishment of stakeholder reference group.  
Lack of control over 
data quality 
Cross-referencing data from multiple sources. Checked secondary 
data against primary data through interviews. 
Absence of key 
variables 
Developed model based on existing data to replace missing data sets. 
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Reliability 
Stability: Is the 
measure stable over 
time? 
Used same data-source for calculation of stock shortages at same 
point in time. One danger is that lack of reliable data was identified 
as one of the problems for the supply chain. This was also a problem 
for the study. 
Inter-observer 
consistency: Is the 
measure consistent 
between observers? 
Almost all site-visits and interviews were undertaken by two 
researchers who swapped roles from one visit to another to secure 
consistency in interpretation of the data. 
Validity 
Face validity: Does the 
measure reflect the 
concept in question? 
Research team constituted a humanitarian logistics practitioner 
expert and a logistics researcher. 
Measurement validity 
Cross-referencing data by using various sources. However, there may 
be inconsistencies in the reporting that are difficult to detect. 
External validity: Can 
results be 
generalized? 
Even though similar problems exist in other regions and countries, 
generalization must be done with great care. Results from this study 
should be corroborated with other similar studies. The check against 
previous studies, both in Uganda and other countries, through the 
document analysis did provide similar evidence of the problems. The 
assumptions made in the Excel model could not be tested against 
real results in similar contexts in this study, but should be done in 
further research. 
Replicability 
Make it possible for 
others to repeat the 
study 
Data collection procedures, sampling method and other aspects of 
the research approach and methodology are well-documented in this 
paper and even more thoroughly in Global Emergency Group (2010). 
 
Particularly important aspects of rigorous action research projects, as suggested by Näslund 
(2008, p.72), were taken into consideration. These aspects included defining the unit of 
analysis, consciousness about the research context and role of the researcher, data collection 
based on multiple sources, and securing good access to data and respondents. 
 
3. THE CONTEXT OF THE KARAMOJA DRUG-SUPPLY CHAIN 
3.1 Overview of the health system In Uganda 
With an annual population growth rate of 3.2 percent, Uganda is one of the fastest growing 
countries in Africa. Of 30.7 million people, 88 percent live in rural areas (MoH, 2008). Since 
the early 1990s, significant progress has been made addressing the HIV epidemic, but this 
still remains a leading cause of morbidity and mortality, in addition to malaria and 
tuberculosis (SCMS, 2009). Major health determinants include low literacy levels, poor 
sanitation, cultural beliefs, physical accessibility, risky behaviors, and prevailing poverty 
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(MoH, 2009). The estimated value of all drugs, including imports for sale, donations, and 
locally manufactured products, is $US 120 million (Elliott, 2008). This accounts for more 
than 30 percent of total expenditures on health and constitutes 10.7 percent of GNP (MoH, 
2007). Uganda’s national health system of organizations and entities are depicted in Figure 1.  
 
<insert Figure 1> 
Figure 1: Key actors within the National Health System (Numbers from Elliott, 2008) 
 
In addition to public, private not-for-profit, and other private hospitals, there are a large 
number of public and private HCs, private retail pharmacies and drug shops (Japan 
International Cooperation Agency, 2008; MoH, 2008). The public and private sectors each 
account for approximately half of Uganda’s health service delivery (MoH, 2009). The private 
sector accounts for 70 percent of the drug supply (I#13). The public system is organized 
around HCs, classified at levels II, III, or IV, depending on staff training, services and 
treatments provided (HCII: parish level served by an enrolled comprehensive nurse; HCIII: 
subcounty level served by a clinical officer; and HCIV: county level served by a medical 
officer). The two main national regulatory bodies are the Ministry of Health (MoH) and the 
National Drug Authority (NDA). MoH provides budgeting, policies, planning, regulations, 
coordination of services, and performance monitoring. NDA is responsible for registering and 
analyzing drugs listed as Essential Medicines and Health Supplies (EMHS). To ensure 
efficient and effective procurement, storage, and distribution of these drugs NMS was 
established in 1993. The NMS base all procurement on competitive tendering, with 
approximately 95 percent imported generic products from India, China, Kenya, South Africa, 
Egypt, and Brazil of which India is by far the largest accounting for 70–80 percent of all 
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imports (I#4). In 2009, NMS got more responsibility for drug procurement, and their annual 
budget increased from $US4.68 million to $US22.68 million.  
 
3.2 Challenges in the Healthcare System 
Two main challenges were identified in this study, based on initial interviews with 
stakeholders (referred to as I#1 to n) and the analysis of the secondary data. First, the public 
health system is underutilized. Second, stock shortages and expired drugs occur at all levels 
in the public system, particularly in rural communities including HCs, DMS, hospitals and 
NMS (Elliot, 2008; MoH, 2009). Table 2 lists the identified causes for the problems:  
 
Table 2: Problems in the Uganda drug-supply chain 
Overall Examples Sources 
Lack of resources 
Funding  MoH, 2009 
Transportation and storage facilities MoH, 2008; Kimera, 2008; I#1; I#3 
Competent staff MoH, 2009; Kimera, 2008; AllAfrica, 
2009; Okuonzi, 2009; I#5 
Limited control of 
drug quantity, 
quality, and 
pricing; leakages 
 
Counterfeiting Wendo, 2008; I#4 
Mark ups Elliot, 2008 
Expired drugs Tebajjukira, 2009 
Lack of transparency and regulation on prices MoH, 2009; Kiapi, 2008; I#14 
Commissions I#14 
Pilfering Kaheru, 2009; I#5 
Lack of 
coordination 
In forecasting Izama, 2009 
Procurement MoH, 2009 
Parallel production MoH, 2008 
Overview of stocks Kimera, 2008; I#5 
Unsolicited drug donations MoH, 2008 
 
Delivery times from NMS to HCs vary from two to four months (Kimera, 2008; MoH 2009). 
At NMS, there is a lack of storage space, funding to procure enough drugs, and capacity to 
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handle the substantial volumes of orders. Lack of efficient funding and ordering processes 
means it can take six months to complete tendering processes (Saturday Monitor, 2009). 
Although many initiatives (warehouse consolidation, new warehouse management systems, 
and better planning cycles) have been introduced, NMS acknowledged: “We [NMS] have not 
been able to supply even 50-60 percent of our mandate.” (I#5). 
 
3.3 The Karamoja Region 
With an estimated population of 1 million, Karamoja accounts for 3.25 percent of the total 
Ugandan population. It is the poorest region, with 87 percent living below the poverty line 
(UBOS, 2009). Meat from livestock, supplemented by cultivated vegetables, wild fruits, and 
greens, make up the basic diet. Over the past decade increased cattle raiding has created 
insecurity in the region. In addition major challenges are poverty, drought, food insecurity, 
reliance on traditional medicine practitioners, and skepticism for the government and public 
system (Stites et al, 2007). With an under-5 mortality rate of 177 per 1,000 live births (among 
the highest in Africa), people in Karamoja has a life expectancy of 47.7 years, as compared to 
the national average of 50.4. The maternal mortality rate is 750 per 100,000 live births, which 
is significantly higher than the national average of 435. The main causes of death in 
Karamoja are pneumonia, malaria, tuberculosis, anemia, meningitis, AIDS, dysentery, 
malnutrition, septicemia and diarrhea (UNICEF, 2009).  
 
In 2008, four of the five Karamoja districts ranked among the lowest 10 percent in the whole 
country on health service delivery (MoH, 2008). There are few private pharmacies and drug 
stores in the region (I#13). Large volumes of unregistered drugs are used (I#13). Food 
insecurity hinders people from using the system because they often do not have the strength 
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to walk to HCs (WFP, 2009) which are located more than 5 km away for more than 70 
percent of the population. There is no public transport, and few people even own a bicycle. 
Almost nobody except international aid organizations has a car. 
 
4. FRAMEWORK FOR SUPPLY CHAIN ANALYSIS  
Constraints in available data suggested a relatively simple conceptual framework to develop 
interview guides and stock-assessment tools, analyze results from the field study, and 
estimate consequences of suggested solutions. Figure 2 shows Persson’s (1995) model and 
presents a set of basic concepts to analyze logistics processes involved in flow of information 
and goods. 
 
<insert Figure 2> 
Figure 2: Logistics Processes as Response Cycles (Adapted from Persson, 1995) 
 
Sections 4.1 to 4.3 present the concepts and how they are linked, while 4.4 presents a set of 
redesign principled for improvements. Section 4.5 presents the logic behind the Excel 
worksheet model to quantify the impact from the solutions. 
 
4.1 Transaction 
Transaction characteristics describe response-cycle behavior, constituting four concepts. Lead 
time is the elapsed time from identifying a need to satisfying it (e.g., time from when an order 
is submitted to when drugs are received). Frequencies mean the number of events per time 
unit (e.g., orders per year). Uncertainties are fluctuations in demand, capacity, lead times, and 
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data accuracy. Expected demand means specific demand patterns (e.g., cyclical variations 
such as seasonal disease outbreaks). In general, longer lead times, lower frequencies, higher 
uncertainties, and uneven demand imply bigger stocks to safeguard against shortages, low 
inventory turnover, and less flexibility for change. 
 
4.2 Structure 
The second set of characteristics constitutes three concepts describing response-cycle 
structure. Complexity is the number of distribution levels (e.g., storage at national, district, 
and HC levels); and distribution points at the same level (e.g., number of DMS). Divisibility 
means the degree of dependence between specific products (e.g., storing measles vaccines 
requires gas for the refrigerator). The more dependence the greater is the need for 
coordination in procurement and other tasks. Predictability is the degree to which it is 
possible to specify the task to perform at a given point in time (e.g., how will an outbreak of a 
specific disease or a large donation of a specific drug impact the existing supply chain and 
extra tasks that must be undertaken). In general, higher complexity, more dependency, and 
lower predictability imply bigger stocks to safeguard against shortages, lower inventory 
turnover, and less flexibility. 
 
4.3 Management 
Finally, management of the response cycle is based on three concepts. Principles are methods 
(such as the pull/push system and forecasting techniques) to manage the supply chain. Tools 
relate to how information is processed and communicated, and the systems used for inventory 
and ordering management (for example, stock cards, electronic order forms). The final point 
addresses how actors are organized in terms of responsibilities regarding specialization and 
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coordination (for example, whether a third-party provider is used, and how a cooperation 
agreement is set up). Consistent and differentiated principles supported by appropriate tools 
and organizational balancing between specialization and integration are essential for securing 
efficient goods and information flows. 
 
4.4 Improving performance by redesigning the logistics processes 
The framework proposes a number of strategies to improve performance (Persson 1995):  
• Reducing or redistributing lead times 
• Reducing or adapting to uncertainties 
• Redistributing or increasing frequencies 
• Eliminating or adapting to expected demand patterns 
• Simplifying structures, systems and processes such as reducing the number of 
distribution points and/or levels 
• Differentiating the way one works with suppliers, products and customers 
• Using postponement strategies so that changes in form, identity, and location occur as 
late as possible in the supply chain 
• Improving information processing and decision support systems 
• Strengthening internal and external integration.  
 
The strategies are highly linked. Increased order frequency and structure simplification by 
reducing the number of storage levels can for example reduce lead times which then lowers 
uncertainties. The goal is to avoid high inventory with according costs and risks of 
obsolescence and damage, while providing flexibility with short and predictable delivery 
times.  
 
Typical logistical tools to handle uncertainties include inventory and materials management 
to get better control, forecasting and/or use of pull principles, and safety stocks to cope with 
uncertainties in demand (Chopra and Meindl, 2010). Replenishment policies, such as 
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continuous or periodic review, are important to keep overview of stocks. The 1970s, with the 
simple use of rules of thumb, combined with lack of coordination between stock locations, 
gave “a bloated inventory system with relatively poor service levels” (ibid, p.334). Recent 
research has shown that decentralization of decisions concerning inventories makes it is 
difficult to reduce overall inventory levels in the supply chain (De Leeuw et al. (2011, p.451).  
 
Despite its shortcomings, forecasting is still a critical management tool to reduce uncertainty, 
particularly if combined with cooperation in the supply chain (Simchi-Levi, 2004, p.32). The 
accuracy of forecasting in push-based supply chains can improve with shorter lead times and 
thus limit disadvantages of push such as obsolete inventory and inability to meet changing 
demand. Shorter lead-times can also make it possible to change to pull (order-based) systems. 
Disadvantages of pull-based supply chains include less ability to take advantage of 
economies of scale and difficulty with implementation unless lead times are very short. 
Hence, solutions that combine push with pull strategies are sought. Postponement exemplifies 
this. Typically, a portion of the supply chain prior to differentiation is operated with push. 
The other part of the supply chain then uses pull to adapt to uncertainty (Simchi-Levi et al. 
2004, p. 45). This can be done both for manufacturing and distribution. For example, stocks 
can be located further upstream in the supply chain at one central location, rather than at 
numerous decentralized locations. This makes it possible to reduce total stocks because of 
aggregation (Chopra and Meindl, 2010, p.334). This can also allow more accurate forecasting 
based on aggregate demand so that safety stocks can be reduced (Ibid. p.307).  
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4.5 Quantifying the impacts of the suggested redesigns 
A cost baseline for the supply chain for two of the six tracer drugs was established and 
compared against the (estimated) costs of the suggested redesigns. The two drugs were 
selected based on convenience sampling: largest amount, and most reliable data. One was 
expensive with many stock shortages (ACT). The other was less expensive with fewer stock 
shortages (Cotrimoxazole). Lack of data on supply-chain costs in general, late deliveries, and 
emergency ordering costs due to stock shortages, required estimations and creativity. In 
response, the researchers created a simple Excel worksheet model, based on classical basic 
formulas that required as little information as possible. The approach is shown in Figure 3.  
 
<insert Figure 3> 
Figure 3: Modeling process and approach 
 
This approach provides a baseline cost, assuming no stock shortages to estimate the cost of 
the current system with all demand fulfilled. The literature recommends using demand rather 
than sales (Chopra and Meindl, 2010, p.222). Annual warehousing, ordering, stock holding 
and transportation costs, and average stock value throughout the supply chain for each of the 
two drugs could then be calculated. This was compared with the cost of the suggested 
solutions with basis in lead time and safety-stock reductions. As in all modeling, 
simplifications and assumptions must be made regards data input and links between factors. 
In this context, where stakeholders had little or no logistics training, it was even more 
important to choose a simple approach to data analysis and presentation. Figure 4 provides an 
overview of the model, while Appendix 3 presents inputs, formulas, and assumptions.  
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<insert Figure 4> 
Figure 4: Model for quantification of solutions’ impact on performance 
 
5. FINDINGS 
Main causes for stock shortages are discussed, while also pointing out positive aspects of the 
supply chain. This is followed by a presentation of suggested solutions and how they may 
impact performance.  
 
5.1 The Karamoja drug supply chain 
While the study focused on areas in the supply chain needing improvement, the field 
assessment discovered many positive elements that can be used as a basis for enhancement:  
• A number of the HCs throughout the region have motivated staff to provide critical 
services under very challenging conditions. 
• Logistics processes and guidelines established through the HMIS include minimum 
two-month safety-stock levels, forced ordering frequencies (ref. USAID Deliver 2011, 
p. 57) of four times per year using a standard set of tools. 
• Stock shortages are a problem, but not for all drugs and not in all facilities. 
• Receiving processes throughout the system appear to work quite well. 
• Some DMS managers seem to have the required formal training, experience, and 
motivation needed to manage logistics requirements. These individuals could support 
and develop others within the district and national system. 
 
Table 3 presents common problems across districts and drugs, It shows lack of sophistication 
in the supply chain and big challenges in each of the processes in the response cycle, as 
section 4 in the framework notes: 
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Table 3: Results from analyzing collected data in the field assessment 
Logistics Processes & Performance Results from interviews/stock-assessments at health facilities 
Forecasting 
No forecasting takes place at any of the four actors at the district level 
No forecasting guidelines are available 
Ordering 
65 percent do not use ordering guidelines provided by the government 
88 percent have no means for electronic handling of information, some 
even lack calculators 
77 percent use emergency ordering 
Missing deliveries are not recorded at any level and must be re-ordered 
Ordering are constrained by lack of funding 
Lack of competence to quantify needs and place orders 
Lack of capacity (human resources) to quantify needs and place orders 
Inventory management 
60 percent had out-of-date stock cards for one or more of the six tracer 
drugs 
55 percent had missing stock cards for one or more of the six tracer 
drugs 
77 percent do not use inventory-management guidelines provided by 
the government 
No use of reference numbers on orders and delivery notes 
Lack of information on deliveries/stock shortages from the supplier NMS 
An abundance of expired drugs without means for safe disposal 
Facilities lack cooling equipment, ventilation, appropriate shelves, and 
cupboards with locks. Many have no electricity/limited access to water. 
Transportation 
Few vehicles and lack of funding to operate them; no fuel/maintenance 
Insecure and bad roads 
Lack of coordination in use of transport means 
Human resources 
One person in the region has a masters degree in supply-chain 
management 
73 percent of the facilities have vacant positions, most for a long time 
Stock outs 
50 percent of the health facilities were-out of ACTs on the day of the 
visit 
86 percent had recorded stock shortages of ACTs for the last 12 months 
Average time of ACT stock shortage was 3.35 months 
Almost all facilities reported inconsistent or no supply of ACTs 
Complexity of handling the ACT considered high because of four variants 
60 percent had stock shortages of other tracer drugs 
Costs No overviews of costs could be provided at any level of the system 
 
Figure 5 depicts the general Karamoja drug-supply chain, including actors, their main 
activities, and the main lead times for information flow from orders placed by HCs until they 
are handled be NMS. It also shows the goods flow from picking and packing at NMS until 
they are received at the HCs. The total average lead time for a drug order to be fulfilled at the 
HCs was 61.2 days. The ordering process from the HC to NMS accounts for 20 percent of 
this time, internal lead time at NMS accounts for 61 percent, and transportation from NMS to 
the HC accounts for 19 percent.4 The lead time is defined as the elapsed time from when the 
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HC identified a need to when it received the according drugs and made them available to 
patients. This included both ordering and receiving, as shown in Figure 5 below. 
 
<insert Figure 5> 
Figure 5: Lead times, actors, and activities undertaken in the response cycle  
 
The NMS and HCs have responsibility for flow of information and goods, whereas health 
subdistricts (HSD) and district health officials (DHO) are responsible only for the 
information flow through order validation and accumulation from centers within their district 
before they pass it on to NMS. Due to lack of electronic communication, orders are 
physically transported from the HCs to the DHO, via the HSD to NMS, where they are 
submitted into the electronic system and processed. DMS act only as pass-throughs for goods 
moving from NMS to HCs, but some hold stocks. This seems quite coincidental and not 
based on any form of analysis of supply and demand.  
 
Together with other variations among and within the districts, this results in unclear division 
of responsibility between actors. Combined with lack of information exchange, the result is 
quite a complex system with little coordination between the flows of goods and information. 
To make up for this complexity and keep secure from stock shortages, the government has 
decided that all HCs should hold two months’ supply of safety stocks of the most essential 
drugs. However, this does not work: there is not enough supply of important drugs, while 
others are overstocked. Table 4 summarizes the main findings from the field assessment and 
analysis, with basis in the conceptual framework. 
 
 20 
Table 4: Transactions, structure and management of the response cycle 
Conceptual Framework & Supply 
Chain Concept 
Definition/Measure Main results from field assessment 
TRANSACTION 
 
 
Lead Time 
Time from order to 
delivery 
HC - NMS: 61.2 days of average lead time 
Frequencies 
How often orders and 
deliveries occur 
HCs order four times a year; that is, every 
three months 
Uncertainties 
 
In lead times for funding, 
ordering, and transport  
Accuracy of data on 
demand, stocks, etc. 
Large variations from one order to the next, 
between districts and for particular drugs 
Highly inaccurate data on consumption and 
stocks, and ordered vs. received quantities 
(i.e., service level). 
STRUCTURE 
Distribution 
Levels 
 
Number of actors in 
information (order) flow 
at district level 
Number of storage levels 
in goods flow at the 
district level 
4: Patient, HC, HSD, DHO 
 
 
1 or 2: HC and DMS when utilized 
Distribution 
Points 
Number of health 
facilities 
 
Total of 94 in Karamoja: five hospitals, four 
HCIV, 29 HCIII, 55 HCII, five DMS, one NMS  
MANAGEMENT 
Management 
Principles 
 
Which guidelines are 
used for forecasting, 
ordering, inventory 
management , storage, 
and transport 
management 
No guidelines for forecasting 
Guidelines for quantification of ordering, 
storage and transport, but little knowledge 
and/or use. 
Management 
Tools 
 
Which tools are used for 
forecasting, ordering, 
inventory management 
,and transport 
Hard-copy forms, no electronic data 
exchange, stock cards, and little means of 
communication apart from physically 
meeting each other. There are three physical 
flows (requiring transport) involved: bringing 
the order form to HCs, bringing the filled 
form back through to NMS, and bringing the 
drugs back to the HCs. 
Organization 
Efficacy of management 
structure and clear 
delineation of 
roles/responsibilities 
Lack of clear roles, too many logistics 
managers without adequate 
competency/capacity, and lack of 
management support or coordination.  
 
The findings suggest there are major deficiencies in the management of the supply chain with 
long and erratic lead times, high supply uncertainty from NMS, and a bureaucratic ordering 
process involving many actors. The complexity in terms of distribution levels and points is 
quite high considering the lack of communication, controls, and transport, which poses 
particular problems for the flow of information, including ordering and feedback regarding 
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stock shortages and deliveries. The process seems to be unnecessarily complicated, allowing 
inconsistencies in practice, even if the processes and responsibilities are theoretically clear.  
With regard to the sharing of responsibility between HSDs, districts and HCs concerning 
information and goods flows, the supply chain is characterized by inconsistent planning, 
forecasting, ordering, and inventory management. Appropriate tools are not used. This leads 
to a lack of coordination between information and goods flows, with the ordering process 
disintegrated from follow up of medical supply deliveries. This means information is lacking 
on what is delivered, as compared to what was ordered. As a result, there are significant 
bottlenecks in the system which, combined with the inability of NMS to fulfill their critical 
supply role, cause frequent stock shortages, unnecessary expiration of drugs, and seemingly 
high cost due to emergency ordering, extra transport, and time-consuming ordering processes. 
 
5.2 Suggested solutions with impact on performance  
Based on the analysis, recommendations for improvements were suggested and quantified, 
using the model presented in section 4.5. The purpose was to clarify and demonstrate basic 
links between logistics processes and performance to the stakeholders, thus providing them 
with better decision support and means to ease implementation of the suggested solutions. 
Table 5 shows suggestions, including quick-win solutions that do not require major changes 
of the system itself but are necessary to rapidly reinforce the system and sustainable solutions 
that require more profound changes of the system. The impacts are quantified and discussed 
below. 
 
Table 5: Solutions with impacts on lead time, safety stock and order frequencies 
Solutions Improvement strategies from 
framework: Impact on lead times, safety 
% 
reduction 
% reduction 
in safety 
Order 
frequency: 
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stock and order frequencies in lead 
time 
compared 
to baseline 
(61.2 days) 
stock 
compared to 
baseline (two 
months) 
no. of 
orders per 
year 
Storage 
Improvement Kit 
and Storage 
Remedies (Quick 
Win #1) 
Improvement in stock-keeping at HCs 
results in more accurate record keeping 
and a better basis for correct and more 
efficient ordering. This reduces 
uncertainty and order lead time (the part 
that concerns time spent in HC) to NMS, 
with reduction in safety stocks. 
0.16% 0.08% 4 
Temporary 
Transport Loan 
Program (Quick Win 
#2)  
Better access to transport reduces 
uncertainty and transport lead time from 
NMS to HCs, with according reduction in 
safety stocks. 
2.47% 1.24% 
 
4 
Process Guideline 
Posters and Rapid 
Training (Quick Win 
#3) 
Training and clear processes will bring an 
improvement in stock-keeping and stock 
management at HCs, resulting in correct 
ordering. This will reduce uncertainty and 
order lead time to NMS, with according 
reduction in safety stocks. 
12.23% 
 
 
6.31% 
 
4 
Electronic Data 
Exchange (Quick Win 
#4) 
Electronic submission of orders reduces 
order lead time to NMS and internal lead 
time at NMS as well as uncertainties with 
according reduction in safety stocks. 
24.46% 
 
13.09% 
 
 
4 
Incorporation of 
District Logistics 
Advisor (Sustainable 
Solution #1)  
Improved forecasting and ordering 
process while ensuring correct data is 
entered reduces order lead time to NMS 
and internal lead time at NMS with 
according reduction in safety stocks. 
Through a more efficient order process 
and with more capacity and competence, 
order frequency can increase, thus 
reducing average cycle stock. 
50% 
 
29% 
 
8 
Establish 
Forecasting Process 
and Move Ordering 
to District Level 
(Sustainable Solution 
#2) 
As above, but even more reduction in 
lead time. Simplification of the structure 
by moving order point and incorporating 
HSD and district levels with the DMS (i.e., 
reducing complexity by fewer distribution 
levels and points and use of 
postponement). Better forecasting also 
means adapting to demand patterns.  
60% 
 
37% 
 
 
8 
Simplify and Reduce 
Logistics Workload 
at Health Centre 
Level (Sustainable 
Solution #3) 
As above. It will most probably be 
possible to treat more patients due to 
increased working capacity, but this does 
not have a direct effect on lead time. 
60% 
 
37% 
 
8 
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Set Clear Transport 
Financing 
Parameters 
(Sustainable Solution 
#4) 
As above. Better funding for transport 
may give more secure long-term 
transportation of both patients and drugs, 
but has not been taken into account in 
the lead time estimation here. 
60% 
 
37% 
 
8 
Move safety stock 
from HCs to DMS 
(Sustainable Solution 
#5) 
Because of fewer uncertainties in the 
system, lead times will be reduced. With 
reduced lead times, supply and demand 
uncertainty will be lower. Safety stocks at 
HCs are replaced by safety stocks at DMS. 
This means reducing the number of 
distribution points for stocks and 
postponing movement of stocks until they 
are needed at HC. Hence, total number of 
units in safety stocks decreases (formula 
in Appendix 3). 
71% 50% 
 
8 
 
The purpose of quick wins is to meet problems related to lack of adequate storage facilities in 
HCs (QW1), transport means (QW2), supply-chain staff competence (QW3), and appropriate 
ordering systems QW4). Improvements in storage, transport, warehouse management, and 
ordering makes it possible to reduce lead times and uncertainties. This requires less safety 
stock and keeps down warehousing and stock-holding costs. It can be debated whether 
improvement of facilities (QW1) will have an effect without appropriate training (QW3) and 
vice-versa, as measures are highly linked. Our argument is that QW1 is a visible means of 
improvement to show that physical storage and control are important and can thus increase 
health personnel’s attention to this part of their job. It becomes a step in capacity building and 
can motivate personnel to participate in supply-chain management training and adopt 
principles and routines.  
 
Electronic ordering instead of physical transport of order forms will reduce the time it takes 
for an order to reach NMS, i.e. at HCs and between HCs and NMS. It will also considerably 
reduce the time it takes to handle orders at NMS, as well as reducing uncertainties due to 
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mistakes in registration of hard-copy order forms. Hence, safety stock can be reduced without 
reducing service levels (i.e., not increasing stock shortages). 
 
With a basis in limited capacity and resourcing at the HCs, the sustainable solutions suggest 
placing less supply-chain responsibility on the HCs. Instead, stronger district supply-chain 
hubs must be developed. By moving order points upstream to DMS, the system allows for 
more frequent ordering, thus reducing demand uncertainty. The sustainable solutions 
proposed are built on the logic that DMS order on behalf of the HCs. This order is based on 
demand forecasts and HCs’ monthly stock reports to reduce uncertainty. These reports use 
systematic periodic review policies, triggering orders for commodities where stock is at the 
minimum level accepted (USAID Deliver 2011, p.57). At this point, the DMS receive the 
medical supplies from NMS for distribution to HCs. The forecast should take into account 
historic consumption, plus additional data on seasonal demands and population changes for 
each HC.  
 
Accordingly, more responsibility is given to the districts (along with required corresponding 
logistics competencies and capacity) for ensuring the last mile of the distribution. This 
affords the HC staff more time to treat patients and focus on reporting correct information 
about stock levels. This centralization of inventory control makes it easier to reduce overall 
inventory levels in the supply chain. Linked with this transfer of responsibility, it is suggested 
to move safety stock from HCs to the five DMS. This will reduce the total safety stock in the 
system (See table 6). Because of lack of funding, there is simply not enough money in the 
system to keep a two-month safety stock at each HC.  
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Table 6: Estimating safety stock in units with use of postponement (details in Appendix 3)  
ACTs - Estimating Safety Stock in Units HCV HCII HCIII HCIV Total 
Total safety stock with centralisation of stock 362478
Total safety stock in current system 610165 380742 176722 89705 1257334
Units safety stock per centre 122033 6923 6094 17941 152990
No. Of centres 5 55 29 5 94
Cotrimoxazole - Estimating Safety Stock in Units HCV HCII HCIII HCIV Total 
Total safety stock with centralisation of stock 164747
Total safety stock in current system 122174 305744 109451 34091 571460
Units safety stock per centre 24435 5559 3774 6818 40586
No. Of centres 5 55 29 5 94
 
In a context of poor roads, this can be risky in terms of transport times and stock shortages. 
However, properly managed safety stocks in the DMS (which is not far from the HCs 
belonging to this district) is a better option than poorly managed or nonexistent safety stock 
at HCs. When an HC is out of stock it can place an emergency order at the district hub rather 
than at NMS, which considerably shortens the lead time. While health personnel at facilities 
can use more of their time for treating patients, staff with supply-chain management training 
can take care of the logistics. Even if there was funding, it is currently very difficult to find 
appropriate personnel for the HCs (See table 2 stating that 73 percent of the HCs have vacant 
positions). The costs of additional personnel and other investments necessary to implement 
the solutions can be covered by the estimated cost reductions as shown in figures 6 and 7. 
 
<insert Figure 6> 
Figure 6: Cost reductions with suggested solutions co-trimoxazole 
 
<insert Figure 7> 
Figure 7: Cost reductions with suggested solutions ACT 
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6. CONCLUSIONS – IMPLICATIONS AND FURTHER RESEARCH 
The study identified causes of stock shortages in the Karamoja public drug-supply chain and 
used the framework to suggest solutions in terms of shortening lead times, increasing order 
frequencies, and reducing uncertainties. This can be done by simplifying the structure, use of 
postponement, implementing better information processing, and strengthening integration. 
Moving ordering upstream based on forecasts, combined with stock reports from the HCs 
may be viewed as going from pull to push. However, the current pulling from HCs is not 
based on real demand or on appropriate overview of stock levels. This, combined with long 
ordering lead times, results in numerous stock shortages at HCs. Moving the safety stocks 
upstream may seem counterintuitive. However, combined with better inventory management 
both at the HC and DMS level, aggregation of demand and stocks will reduce uncertainties 
and the cost of total stock in the system.  
 
The results from the study are very much in line with what Kaufmann et al. (2011) claim is 
needed: better forecasting and inventory management through integration of the supply chain, 
reducing complexity by eliminating stocks, and providing better information exchange and 
stronger supply-chain competence. In contrast to Kaufmann et al. (2011), this study 
developed an approach with framework and model that can demonstrate why changes 
improve the performance of the supply chain. Strategies for reduction of inventory as put 
forward in the literature (e.g., Baker, 2007) are analyzed in a new context and include means 
for improving visibility of end-consumer demand to all supply-chain participants, 
compression of total lead time and centralization of inventory.  
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Recent research on supply-chain complexity (Manuj and Sahin, 2011) suggests that 
complexity can lead to higher total costs, longer lead times, poor delivery performance, and 
higher uncertainty. This can be mitigated by use of information technology and training. 
Results from this study are partly in line with this. However, the reality of the Karamoja 
drug-supply chain shows that complexity does not have to be taken as a given and can be 
reduced through relatively simple means.  
 
It may seem counterintuitive to meet big stock shortages with reductions in safety stock. 
However, by reducing uncertainties and lead times, the need for safety stocks is reduced, 
while at the same time avoiding under-stocking. This is line with lean principles suggesting 
that inventories hide problems and are wasted resources (Womack et al. 1990). The two 
months’ safety-stock levels lead to overstocking of some drugs and results in lack of other 
important drugs because funding is limited. Accordingly, the challenge was to identify causes 
of stock shortages related to the supply chain and calculate how changes can improve the 
availability of drugs at the HC level, given specific constraints in terms of physical and 
financial infrastructures. 
 
The framework and model was developed with simplicity in mind, balanced against the need 
for rigor in quantifying the impact of the suggested solutions. This is necessary in action 
research that “strive[s] to contribute to both the practical concerns…and to the goals of 
science.” (Näslund, 2008, p.72).  
 
In line with suggestions by Tatham and Pettit (2010), this study has shown how models 
developed for the commercial context can be applied to the humanitarian. The application of 
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the basic model for logistics process redesign demonstrates its strengths in terms of simplicity 
and usefulness when information is scarce, data collection is challenging, and the main 
stakeholders are not competent in logistics and supply-chain management. Research should 
continue to focus on simple and applicable tools used in a context characterized by lack of 
financial resources, infrastructure, competence, and capacity.  
 
The study provides substantial data and knowledge on an issue of great importance in most 
developing countries. It contributes empirical insight much needed in humanitarian logistics. 
Further research could link studies like this with another area of research, namely global 
health supply chains (e.g. Chick et al. 2008). Even though this study focus on a particular part 
of a specific country in the African continent, similar problems exist in other countries and 
regions challenged by lack of financial resources, health system infrastructure, capacity, and 
competence. Causes of the problems and solutions in this study are similar to those noted in 
other studies (e.g., Kaufmann et al., 2011), and should thus be applicable elsewhere. 
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APPENDIX 1: SITE VISITS IN KARAMOJA 
District County Sub-County Parish  
UBOS 
Population 
Projection  
2008 
Govt
*
PNFP
*
Name of the Facility
HC V 
Hospital
HC 
IV
HC III HC II
Total no. 
of 
facilities 
assessed
Abim Labwor 1 District Medical Store 1 1
Abim Labwor
Abim Town 
Council
Town Council / 
Wiawer 5652 1 Abim 1 1
Abim Labwor Alerek Koya 2681 1 Koya 1 1
Abim Labwor Lotukei Awach 4059 1 Awach 1 1
Abim Labwor Morulem Aremo 4707 1 Morulem 1 1
Abim 17099 5 0 1 1 0 1 2 5
Kaabong 1 District Medical Store 1 1
Kaabong Dodoth Kathile Kathile 1 Kathile 1 1
Kaabong Dodoth Kalapata Kalapata 1 Kalapata 1 1
Kaabong Dodoth Kalapata Kamion 1 Kamion 1 1
Kaabong Dodoth Sidok Langaro 1 Kopoth 1 1
Kaabong Dodoth Kaabong  TC Central 1 Kaabong 1 1
Kaabong 281400 6 0 1 1 0 2 2 6
Kotido 1 District Medical Store 1 1
Kotido Jie Kacheri Kacheri 1 Kacheri 1 1
Kotido Jie Kacheri Losakucha 1 Losakucha 1 1
Kotido Jie Kotido TC Kotido west 1 Kotido 1 1
Kotido Jie Panyangara Loletio 1 Panyangara 1 1
Kotido 179306 5 0 1 0 1 1 2 5
Moroto 1 District Medical Store 1 1
Moroto Bokora Lopeei Lopeei 5000 1 Lopeei 1 1
Moroto Bokora Matany Lukuwas 13100 1 Matany Hospital 1 1
Moroto Bokora Iriir Iriir 10400 1 Iriri 1 1
Moroto Matheniko Katikekile Natumukale 5300 1 Lopelipel 1 1
Moroto Matheniko Katikekile Tapac 7500 1 Tapac 1 1
Moroto 41300 4 2 1 1 0 3 1 6
Nakapiripirit 1 District Medical Store 1 1
Nakapiripirit Pian Lolachat Lotaruk 4700 1 Lolachat 1 1
Nakapiripirit Chekwi Kamkomogole Tokora 3600 1 Tokora 1 1
Nakapiripirit Chekwi Namalu Loregae 14600 1 Nabulenger 1 1
Nakapiripirit Pokot Karita Karita 13400 1 Karita 1 1
Nakapiripirit 36300 5 0 1 0 1 2 1 5  
APPENDIX 2: LIST OF INTERVIEWS 
Organization Interviewee Position/Location Interview Date 
Chief, Moroto Zonal Office 
for Karamoja and Teso, 
UNICEF  
Narinder Sharma Moroto Various 
Admin Assistant, UNICEF  Thomas Ochom Moroto Various 
Health & Nutrition, 
UNICEF  
Joanna Nikulin Moroto Various 
HIV specialist, UNICEF Francis Nyakojoo Moroto Various 
Health & Nutrition, 
UNICEF 
Charles Wilfred Ochieng Moroto Various 
Nutrition Specialist, 
UNICEF 
Brenda Akwanyi Moroto Various 
World Food Programme 
(WFP) 
Rohit Pal Moroto Various 
UNICEF Dr. Claudia Hudspeth Chief, Health & Nutrition 03.10.09 
MoH Ms. Khalid Mohammed  Consultant at Pharmacy Division, 
Coordinator of the NPSSP Plan 
20.10.09 
JMS Mr. Andrew C.W. 
Nsubuga 
Operations Manager 20.10.09 
WHO Dr. Soloman Fisseha Medical Officer and Emergency 
Cluster Lead Co-ordinator 
21.10.09 
MoH Dr. Martin Oteba Assistant Commissioner in Charge 
of Pharmaceutical Supplies, 
International Health Specialist, 
22.10.09 
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Pharmacist 
MoH Dr. Gideon Kisuule  Principal Pharmacist, Pharmacy 
Division 
22.10.09 
NMS Mr. Kamabare Moses General Manager 23.10.09 
Kampala Pharmaceutical 
Industries Ltd. 
Mr. Anthony Kuria Business Development Manager 23.10.09 
Quality Chemicals 
Industries Ltd 
Mr. Nalima Geofrey Marketing Manager 26.10.09 
NDA B. Pharm Okello Okidi 
Simmons 
Inspector of Drugs 27.10.09 
Danida Mr. Frans Bosman Medicines Management Advisor 28.10.09 
Danida Mr. Claes Brom Senior Advisor 28.10.09 
SURE Ms. Birna Trap Chief of Party 28.10.09 
UNICEF Ms. Anna Spindler Supply Manager 23. & 30.10.09 
ICRC Dr. Stephane Du Mortier Medical Co-ordinator 02.11.09 
UNFPA Dr. Ismail Ndifuna National Programme Officer 
(Reproductive Health) 
02.11.09 
UNFPA Dr. Primo Madra National Programme Officer 
(Emergencies) 
02.11.09 
UNICEF Mr. Phillips LimLim Programme Officer, Health & 
Nutrition 
03.11.09 
DHI Dr Martin Lyra Moroto 09.11.09 
OCHA Kasper Enghorg Moroto 09.11.09 
Health Sub-District 
Matany Hospital 
Achia Debora in the 
absence of Dr Bruno 
Moroto (Matany Hospital) 10.11.09 
CUAMM- TA Dr Bernard Otucu Moroto 11.11.09 
Senior Supplies Officer Locul Festo District Medical Store, Moroto 11.11.09 
Senior Nurse Sister Rosario Matany Hospital, Moroto 11.11.09 
Registered Midwife Irene Apio Tapac HCIII, Moroto 12.11.09 
Enrolled Nurse David Loitakol Lopelipel HCII Moroto  12.11.09 
Nursing Officer Koder Joshua Lopeei HCIII, Moroto 13.11.09 
CAO  Walakira Paul  Kotido 16.11.09 
Store Assistant Mary Mudong Kotido HCIV 16.11.09 
Clinical Officer Joseph Sapurr Kotido HCIV 16.11.09 
Senior Clinical Officer Ignatius Lodokyo Kacheri HCIII, Kotodo 17.11.09 
Nursing Assistant Labega Ensio Losakucha HCII, Kotido 17.11.09 
Nursing Officer Moding Celestine Panyangara HCIII, Kotodo 18.11.09 
DHO Dr Omeke Michael Moroto 19.11.09 
DHO Dr Okio Talamoi Kotido 16. & 19.11.09 
CUAMM – TA Dr Philip Olinga Kotido 16. & 19.11.09 
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CUAMM- TA Dr Rogers Ayoko Abim 19.11.09 
DHO Dr Kisambu James Kaabong 19.11.09 
CUAMM –TA Dr Simon Aliga Kaabong 19.11.09 
CUAMM –TA Tudo John Bosco Nakapiripirit 19.11.09 
Nakapiripirit DHI Philip Siloi Nakapiripirit 19.11.09 
IRC Raphael Ogutu & Mr. 
Epiu Leonard Stephen 
Moroto 19.11.09 
HCT/PMTCT Aboka Moses Moroto 19.11.09 
ACF-USA Edward Kutindo  Moroto 19.11.09 
CUAMM- TA Regional Dr Giovanni Dallogilo Moroto 20.11.09 
Italian Embassy, 
Development Cooperation 
Office 
Dr Pier Luifi Rossanigo 
Moroto Diocese 20.11.09 
Store Assistant Goeffey Okogo District Medical Store, Abim 23.11.09 
Store health Assistant Owilli John Logira HCV Abim Hospital 23.11.09 
Nursing Officer Ojum Benson Koya HCII, Abim 24.11.09 
Nursing Assistant Akidi Christie Awach HCII, Abim 24.11.09 
Accounting Assistant Basil Morulem HCIII, Abim 24.11.09 
Record Assistant Bradford Morulem HCIII, Abim 24.11.09 
Supplies Officer  Max Ben District Medical Store, Kotido 25.11.09 
Health Sub-District  Dr Sherif Kaabong 26.11.09 
Senior Supplies Officer Lokiru Gabriel Tirach District Medical Store, Kaabong 26.11.09 
Assistant supply officer Ayolo Alex Alinga HCV Kaabong Hospital 26.11.09 
Store Assistant Betty Ayola HCV Kaabong Hospital 26.11.09 
Senior clinical officer Angella John Bosco Kathile HCIII, Kaabong 26.11.09 
Nursing Assistant Chilla Methew Kamion HCII, Kaabong 30.11.09 
Registered Comprehensive 
Nurse 
Omara Alfred Daniel 
Kalapata HCIII, Kaabong 30.11.09 
Registered Comprehensive 
Nurse 
Okello William 
Kopoth HCII, Kaabong 01.12.09 
Nursing assistant Logwe Zakary Kopoth HCII, Kaabong 01.12.09 
Nakapiripirit DHO Dr John Anguzu Nakapiripirit 02.12.09 
Assistant Supply Officer  
Edward Ogwang 
District Medical Store, 
Nakapiripirit 
03.12.09 
Senior Nursing Officer Langgin Sisto Assis Tokora HCIV, Nakapiripirit 03.12.09 
Clinical Officer Turkey Solomon Karita HCIII, Nakapiripirit 03.12.09 
Registered Midwife Alirach Jane Karita HCIII, Nakapiripirit 03.12.09 
Nursing Assistant Boniface Chuma Nabulenger HCII, Nakapiripirit 04.12.09 
Enrolled Nurse Limlim Teddy Lolochat HCIII, Nakapiripirit 04.12.09 
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APPENDIX 3: INPUT AND ASSUMPTIONS FOR MODEL 
With basis in order frequency, lead time, consumption data and cost estimates (warehousing, order, transport 
and stock holding cost) the model calculates order quantity, average units in stock and safety stock levels  
 
Input data: 
INPUT DATA SOURCE/ESTIMATION HC 
No. of health centers of 
each level (II, III, IV) 
List from OCHA 10th June 2009 excluding 'non-functional' centers. 
Consumption in 
pills/month at different HC 
levels 
From field assessment: Usage last 12 months in each HC divided by the number of 
months when the drugs are available (12 less no. of months with stock shortages). 
Consumption per HC-type is then multiplied by no. of the same HCs.  
Average Unit cost 
(Procurement cost per unit) 
ACT: Values from HMIS018 form: Average 
(of the 4 types): 0,115USD per pill. 
Co-trimoxazole 480gr: Values from 
HMIS018 form: 0,0120 per pill. 
Order cost per order  From field assessment: Time spent on ordering * Wage for HC-personnel*share of 
total order 
Transport cost/order Based on field assessment and data from UNICEF: Distances and transport costs 
Kampala to Karamoja and District HCs respectively in MT/km. Conversion ratios to 
m3/km and share of order for each drug. 
Stock holding cost includes 
interest rate, obsolescence, 
leakage, etc. 
Set at 24 percent of stock value. High because of much leakage; that is, the more 
drugs in the supply chain, the more leakage. 
 
Safety stock level starting 
value 
HMIS guidelines: Minimum stock level of two months’ consumption (real demand; 
that is, corrected for stock shortages). 
 
Formulas: 
Order quantity = annual consumption/order frequency 
Average units in stock = (order quantity-safety stock)/2+safety stock 
Safety stock units = safety stock level*consumption 
Safety stock = starting value safety stock* square root of lead time*starting value lead time 
Starting values =  
-- Lead times (two months) 
-- Safety stock (two months’ demand (assuming no stock shortages) 
-- Order frequency (four per year) 
 
Assumptions:  
Current system is modeled without DMS which is an underestimation of real cost as they do help in ordering 
and transport as well as some of them keeping stocks. The same assumption is used in the modeling of all new 
solutions. Full implementation of all solutions is modeled with DMS only as a place for keeping safety stock on 
behalf of the health facilities adding an uncertainty factor of 25 percent to account for the special 
circumstances in the region. This has been calculated as follows: 
Total stock in new system = 1.25*(square root (no. of storage points in new system; i.e., 5)/square root (no. of 
storage points in current system, i.e. 94))*(total stock in current system) (see, e.g., Maister, 1976) 
 
Quantification of performance impact from solutions: 
Each solution’s impact was quantified in terms of  percent-reduction in lead times based on the conceptual 
framework and other literature, secondary sources and the field assessment. The suggested lead time 
reductions in  percent can be debated, but lack of data required assumptions, taking the specific context into 
account. In the table QW1-QW4 relate to what are commented upon as ‘quick-wins’ in the text, while ‘SS’ 
refers to ‘sustainable solutions’. The numbers provided are lead time in days. 
Lead time 
Current 
System 
QW1 QW2 QW3 QW4 SS1 SS2 SS3 SS4 SS5 
Order HC 1.0000 0.9000 0.8800 0.8500 0.7000 0.5000 0.4000 0.4000 0.4000 0.2500 
Order to 
NMS 
11.2000 11.2000 11.2000 9.5200 7.8400 5.6000 4.4800 4.4800 4.4800 2.8000 
Order at 
NMS 
26.1000 26.1000 26.1000 22.1850 18.2700 13.0500 10.4400 10.4400 10.4400 6.5250 
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Pack at NMS 11.3000 11.3000 11.3000 11.3000 11.3000 5.6500 4.5200 4.5200 4.5200 2.8250 
Transport 9.6000 9.6000 8.4480 8.1600 6.7200 4.8000 3.8400 3.8400 3.8400 2.4000 
Receipt HC 2.0000 2.0000 1.7600 1.7000 1.4000 1.0000 0.8000 0.8000 0.8000 0.5000 
Total Lead 
Time in days 
61.2000 61.1000 59.6880 53.7150 46.2300 30.6000 24.4800 24.4800 24.4800 15.3000 
Total in 
months 
2.0400 2.0367 1.9896 1.7905 1.5410 1.0200 0.8160 0.8160 0.8160 0.5100 
% change 
specific lead 
time (bold) 
0 % 10 % 12 % 15 % 30 % 50 % 60 % 60 % 60 % 75 % 
           
Safety stock 
level 
2.0000 1.9984 1.9751 1.8737 1.7383 1.4142 1.2649 1.2649 1.2649 1.0000 
Order 
frequency 
4 4 4 4 4 8 8 8 8 8 
 
                                                 
1Although a number of these sources refer to the Ministry of Health (MoH), they were undertaken by 
consultants and researchers on behalf of the MoH, not by the MoH itself. Naturally, however, care should be 
taken when it comes to objectivity, which is why data has been cross-referenced. Lack of data is one of the 
challenges in developing countries. By meeting a large number of stakeholders and working in Uganda on 
behalf of UNICEF for such a long time, this project had access to data that would otherwise have been 
inaccessible. 
2Available from the authors upon request. 
3For the sake of anonymity, interviews undertaken are numbered and do not correspond to the listing in 
Annex 2.  
4Numbers have been calculated from results from previous studies (MoH 2009d), our own field assessment in 
Karamoja and interviews at district and national level. They represent averages across all drugs and are based 
on samples of orders and health centers.  
